1-8 of 8
D Fisher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

How Time Spent on Rituximab Infusion Impacts Patient Satisfaction, Stress, Employment, and Caregiver Burden

Maxine D Fisher, PhD, Christopher Wallick, PharmD, Paul J Miller, PhD, Mark S Walker, PhD, Stephen Lash, PharmD, Keith L Dawson, DNP, Carolina M Reyes, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5666.
https://doi.org/10.1182/blood.V130.Suppl_1.5666.5666
Published: 2017
Journal Articles

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

Ajay K. Kakkar, MBBS, PhD, Giancarlo Agnelli, William D. Fisher, MD, Daniel George, Patrick Mouret, Michael R. Lassen, MD, Patrick Mismetti, Judith Murphy, Alexander G.G. Turpie
Journal: Blood
Blood (2010) 116 (21): 188.
https://doi.org/10.1182/blood.V116.21.188.188
Published: 2010
Journal Articles

Phase II Dose-Finding Study with TAK-442, An Oral Factor Xa Inhibitor, in Patients Undergoing Elective Knee Arthroplasty.

Jeffrey I. Weitz, MD, FACP, FRCP, Charlie Cao, Ph.D., Bengt Eriksson, MD, William D. Fisher, MD, Stuart Kupfer, MD, Gary E Raskob, PhD, Jeffrey Spaeder, MD, Alexander GG Turpie, MD
Journal: Blood
Blood (2009) 114 (22): 170.
https://doi.org/10.1182/blood.V114.22.170.170
Published: 2009
Journal Articles

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1

Robert C. Carlisle, Ying Di, Anna M. Cerny, Andreas F.-P. Sonnen, Robert B. Sim, Nicola K. Green, Vladimir Subr, Karel Ulbrich, Robert J. C. Gilbert, Kerry D. Fisher, Robert W. Finberg, Leonard W. Seymour
Journal: Blood
Blood (2009) 113 (9): 1909–1918.
https://doi.org/10.1182/blood-2008-09-178459
Published: 2009
Includes: Supplemental data
Journal Articles

Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.

Alexander G.G. Turpie, MD, Kenneth Alan Bauer, MD, Lars Borris, MD, Ola E. Dahl, MD, PhD, William D. Fisher, MD, Michael Gent, MD, PhD, Sylvia Haas, MD, Menno V. Huisman, MD, PhD, Ajay K. Kakkar, MD, PhD, Peter Kälebo, MD, PhD, Louis M. Kwong, MD, Martin Homering, PhD, Frank Misselwitz, MD, PhD, Bengt I. Eriksson, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 277.
https://doi.org/10.1182/blood.V106.11.277.277
Published: 2005
Journal Articles

Study of Treatment Patterns and Consequences of Immune Thrombocytopenic Purpura (ITP).

Maxine D. Fisher, PhD, Grace Yang, MPA, Lauren P. Burawski, MA, Kelly M. Grotzinger, PhD, MBA, Andrew B. Provan, MD, John J. Barron, PharmD
Journal: Blood
Blood (2005) 106 (11): 5593.
https://doi.org/10.1182/blood.V106.11.5593.5593
Published: 2005
Journal Articles

Reduced invasion and growth of Plasmodium falciparum into elliptocytic red blood cells with a combined deficiency of protein 4.1, glycophorin C, and p55

AH Chishti, J Palek, D Fisher, GJ Maalouf, SC Liu
Journal: Blood
Blood (1996) 87 (8): 3462–3469.
https://doi.org/10.1182/blood.V87.8.3462.bloodjournal8783462
Published: 1996
Journal Articles

Phosphorylation of protein 4.1 in Plasmodium falciparum-infected human red blood cells

AH Chishti, GJ Maalouf, S Marfatia, J Palek, W Wang, D Fisher, SC Liu
Journal: Blood
Blood (1994) 83 (11): 3339–3345.
https://doi.org/10.1182/blood.V83.11.3339.3339
Published: 1994